Figure 3.
Tornado diagram of the one-way sensitivity analysis results. (A) The output of all patients group. (B) The output of HR-positive subgroup.
Abbreviations: T-DXd, trastuzumab deruxtecan; BSA, body surface area; OS, overall survival; PFS, progression-free survival; PD, progressed disease; ICUR, incremental cost-utility ratio; QALY, quality-adjusted life-year; WTP, willingness to pay; HR, hazard ratio; HR+, hormone-receptor positive;